Toripalimab Injection: clinical trials recruiting now

Phase breakdown

Conditions being studied

Recruiting trials involving Toripalimab Injection

• A Clinical Trial of SHR-A1811 in the Treatment of Triple-negative Breast Cancer
  NCT07111832 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 2 locations
• A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer
  NCT07281976 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 7 locations
• A Trial of LBL-024 Monotherapy, LBL-024 Combined With LBL-007 or Toripalimab in Patients With Advanced Melanoma
  NCT07099430 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06095583 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 76 locations

Common questions

How many recruiting trials involve Toripalimab Injection?

4 recruiting trials across 7 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.